Table 3 Mean and (SD) of spatiotemporal gait parameters for all patients before (Pre 1 and Pre 2 and after (Post 1) fampridine
From: Fampridine and quality of life in individuals with multiple sclerosis
Spatiotemporal gait parameters | All patients (n = 50) | ||
|---|---|---|---|
Pre 1 | Pre 2 | Post 1 | |
Velocity (m s−1) | 1.05 (0.49) | 1.08 (0.51) | 1.2 (0.48)** |
Cadence (steps min−1) | 105.18 (28.74) | 106.57 (28.98) | 112.79 (24.9)** |
Step length (m) | 0.57 (0.17) | 0.58 (0.18) | 0.62 (0.16)** |
Step time (s) | 0.63 (0.25) | 0.62 (0.22) | 0.56 (0.16)** |
Step width (m) | 0.13 (0.05) | 0.13 (0.05) | 0.12 (0.04)* |
Stance time (% GC) | 66.03 (5.39) | 65.83 (5.6) | 64.13 (4.51) £ |
Double supp. time (% GC) | 32.53 (10.84) | 31.91 (11.27) | 29.06 (8.23) £ |